levitra sulfur
The maximum decrease in blood pressure occurred between 1 and 4 hours after dosing. Concomitant treatment should be initiated only if the patient is stable on his alpha blocker therapy. Physicians should also discuss with patients the increased risk of NAION in individuals who have already experienced NAION in one eye, including whether such individuals could be adversely affected by use of vasodilators such as PDE5 inhibitors (see POST-MARKETING EXPERIENCE, Ophthalmologic). If you become pregnant, contact your doctor. There were no other instances of outlier blood pressure values (standing SBP <85 mmHg or decrease from baseline in standing SBP of >30 mmHg). Top More Levitra resources Levitra Prescribing Information (FDA) Levitra Detailed Consumer Information (PDR) Levitra Advanced Consumer (Micromedex) - Includes Dosage Information Levitra MedFacts Consumer Leaflet (Wolters Kluwer) Levitra Consumer Overview
Levitra
Generic Name: vardenafil (var DEN a fil)
Brand Names: Levitra
What is vardenafil?
Vardenafil relaxes muscles and increases blood flow to particular areas of levitra sulfur body.
Vardenafil is used to treat erectile dysfunction (impotence).
Vardenafil may also be used for purposes other than levitra sulfur listed in this medication guide.
What is the most important information I should know about vardenafil?
Do not take vardenafil if you are also using a nitrate drug for chest pain or heart problems. Contact your doctor or seek emergency medical attention if your erection is painful or lasts longer than 4 hours. Package Strength NDC Code Bottles of 30 2.5 mg 0085 - 1923 - 01 5 mg 0085 - 1945 - 01 10 mg 0085 - 1901 - 01 20 mg 0085 - 1934 - 01 Recommended Storage: Store at levitra sulfur (77°F); excursions permitted to 15-30°C (59-86°F) . In the rat pre-and postnatal development study, the NOAEL (no observed adverse effect level) for maternal toxicity was 8 mg/kg/day. This improvement in mean score was maintained at all doses at 6 months in the North American trial. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you: if you are pregnant, planning to become pregnant, or are breast-feeding if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement if you have allergies to medicines, foods, or other substances if you have a deformed penis (eg, cavernosal fibrosis, Peyronie disease), blood cell problems (eg, leukemia, multiple myeloma, sickle cell anemia), or any other condition that may increase the risk of a prolonged erection (priapism) levitra sulfur you have a history of a prolonged (more than 4 hours) or painful erection (priapism) if you have a history of certain eye problems (eg, macular degeneration, optic neuropathy, retinitis pigmentosa, sudden vision loss) or hearing problems (eg, ringing in the ears, decreased hearing, hearing loss) if you have a history of liver or kidney problems, dialysis, high or low blood pressure, ulcers, seizures, lung problems (eg, pulmonary veno-occlusive disease), bleeding problems, blood vessel problems, or heart problems (eg, angina, aortic stenosis, heart failure) if you have a history of heart attack, stroke, a certain type of irregular heartbeat (long QT syndrome), or a family history of long QT syndrome Some MEDICINES MAY INTERACT with Levitra. Table 2: Mean (95% C.I.) maximal change from baseline in systolic blood pressure (mmHg) following vardenafil 5 mg in BPH patients on stable alpha-blocker therapy (Study 1) Alpha-Blocker Simultaneous dosing of Vardenafil 5 mg and Alpha-Blocker, Placebo-Subtracted Dosing of Vardenafil 5 mg and Alpha-Blocker Separated by levitra sulfur Hours, Placebo-Subtracted Terazosin 5 or 10 mg daily Standing SBP -3 (-6.7, 0.1) -4 (-7.4, -0.5) Supine SBP -4 (-6.7, -0.5) -4 (-7.1, -0.7) Tamsulosin 0.4 mg daily Standing SBP Supine SBP -6 (-9.9, -2.1) -4 (-7.0, -0.8) -4 (-8.3, -0.5) -5 (-7.9, -1.7) Blood pressure effects (standing SBP) in normotensive men on stable dose tamsulosin 0.4 mg following simultaneous administration of vardenafil 5 mg or placebo, or following administration of vardenafil 5 mg or placebo separated by 6 hours are shown in Figure 3. Follow the directions on your prescription label. This helps you to achieve and maintain an erection. Primary efficacy assessment in all four major trials was by means of the Erectile Function (EF) Domain score of the validated International Index of Erectile Function (IIEF) Questionnaire and two questions from the Sexual Encounter Profile (SEP) dealing with the ability to achieve vaginal penetration (SEP2), and the ability to maintain an erection long enough for successful intercourse (SEP3). Patients should be levitra sulfur of the possible occurrence of symptoms related to postural hypotension and appropriate countermeasures. Do not use this medication without telling your doctor if you are breast-feeding a baby. In some patients the use of PDE5 inhibitor drugs, including Levitra, with alpha-blockers can lower blood pressure significantly leading to fainting. If you have severe kidney or liver problems, a bleeding disorder, stomach ulcer, or an inherited retinal disorder such as retinitis pigmentosa, use Levitra with caution. Primary efficacy assessment in all four major trials levitra sulfur by means of the Erectile Function (EF) Domain score of the validated International Index of Erectile Function (IIEF) Questionnaire and two questions from the Sexual Encounter Profile (SEP) dealing with the ability to achieve vaginal penetration (SEP2), and the ability to maintain an erection long enough for levitra sulfur intercourse (SEP3). Following a single oral dose of 20 mg vardenafil in healthy volunteers, a mean of 0.00018% of the administered dose was obtained in semen 1.5 hours after dosing. WHAT IMPORTANT INFORMATION SHOULD YOU KNOW ABOUT Levitra? Levitra can cause your blood pressure to drop suddenly to an unsafe level if it is taken with certain other medicines. Levitra 2.5 mg Label 08917771 NDC 0085-1923-01 Levitra® (VARDENAFIL HCI) TABLETS Equivalent to 2.5 mg vardenafil Rx only levitra sulfur Tablets Levitra 5 mg Label 08917666 NDC 0085-1945-01 Levitra® (VARDENAFIL HCI) TABLETS Equivalent levitra sulfur 5 mg vardenafil Rx only 30 Tablets Levitra 10 mg Label 08917674 NDC 0085-1901-01 Levitra® (VARDENAFIL HCI) TABLETS Equivalent levitra sulfur 10 mg vardenafil Rx only 30 Tablets Levitra 20 mg Label 08917690 NDC 0085-1934-01 Levitra® (VARDENAFIL HCI) TABLETS Equivalent to 20 mg vardenafil Rx only 30 Tablets Levitra vardenafil hydrochloride tablet, film coated Product Information Product Type HUMAN PRESCRIPTION DRUG NDC Product Code (Source) 0085-1923 levitra sulfur of Administration ORAL DEA Schedule Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength VARDENAFIL HYDROCHLORIDE (VARDENAFIL) VARDENAFIL HYDROCHLORIDE 2.5 mg Inactive Ingredients Ingredient Name Strength CELLULOSE, MICROCRYSTALLINE CROSPOVIDONE SILICON DIOXIDE MAGNESIUM STEARATE HYPROMELLOSE POLYETHYLENE GLYCOL TITANIUM DIOXIDE FERRIC OXIDE YELLOW FERRIC OXIDE RED Product Characteristics Color ORANGE Score no score Shape ROUND Size 6mm Flavor Imprint Code BAYER;2;5 Contains Packaging # NDC Package Description Multilevel Packaging 1 0085-1923-01 30 TABLET In 1 BOTTLE, PLASTIC None Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date NDA NDA021400 05/15/2008 Levitra vardenafil hydrochloride tablet, film coated Product Information Product Type HUMAN PRESCRIPTION DRUG NDC Product Code (Source) 0085-1945 Route of Administration ORAL DEA Schedule Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength VARDENAFIL HYDROCHLORIDE (VARDENAFIL) VARDENAFIL HYDROCHLORIDE 5 mg Inactive Ingredients Ingredient Name Strength CELLULOSE, MICROCRYSTALLINE CROSPOVIDONE levitra sulfur DIOXIDE MAGNESIUM STEARATE HYPROMELLOSE POLYETHYLENE GLYCOL TITANIUM DIOXIDE FERRIC OXIDE YELLOW FERRIC OXIDE RED Product Characteristics Color ORANGE Score no score Shape ROUND Size 6mm Flavor Imprint Code BAYER;5 Contains Packaging # NDC Package Description Multilevel Packaging 1 0085-1945-01 30 TABLET In 1 BOTTLE, PLASTIC None Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date NDA NDA021400 05/15/2008 Levitra vardenafil hydrochloride tablet, film coated Product Information Product Type HUMAN PRESCRIPTION DRUG levitra sulfur Product Code (Source) 0085-1901 Route of Administration ORAL DEA Schedule Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength VARDENAFIL HYDROCHLORIDE (VARDENAFIL) VARDENAFIL HYDROCHLORIDE 10 mg Inactive Ingredients Ingredient Name Strength CELLULOSE, MICROCRYSTALLINE CROSPOVIDONE SILICON DIOXIDE MAGNESIUM STEARATE HYPROMELLOSE POLYETHYLENE GLYCOL TITANIUM DIOXIDE FERRIC OXIDE YELLOW FERRIC OXIDE RED Product Characteristics Color ORANGE Score no score Shape ROUND Size 7mm Flavor Imprint Code BAYER;10 Contains Packaging # NDC Package Description Multilevel Packaging 1 0085-1901-01 30 TABLET In 1 BOTTLE, PLASTIC None 2 0085-1901-03 1 BLISTER PACK In 1 CARTON contains a BLISTER PACK 2 2 TABLET In 1 BLISTER PACK This package is contained within the CARTON (0085-1901-03) Marketing Information Marketing levitra sulfur Application Number or Monograph Citation Marketing Start Date Marketing End Date NDA NDA021400 05/15/2008 Levitra vardenafil hydrochloride tablet, film coated Product Information Product Type HUMAN PRESCRIPTION DRUG NDC Product Code (Source) 0085-1934 Route of Administration ORAL DEA Schedule Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength VARDENAFIL HYDROCHLORIDE (VARDENAFIL) VARDENAFIL HYDROCHLORIDE 20 mg Inactive Ingredients Ingredient Name Strength CELLULOSE, MICROCRYSTALLINE CROSPOVIDONE SILICON DIOXIDE MAGNESIUM STEARATE HYPROMELLOSE POLYETHYLENE GLYCOL TITANIUM DIOXIDE FERRIC OXIDE YELLOW FERRIC OXIDE RED Product Characteristics Color ORANGE Score no score Shape ROUND Size 8mm Flavor Imprint Code BAYER;20 Contains Packaging # NDC Package Description Multilevel Packaging 1 0085-1934-01 30 TABLET In 1 BOTTLE, PLASTIC None 2 0085-1934-03 1 BLISTER PACK In 1 CARTON contains a BLISTER PACK 2 2 TABLET In 1 BLISTER PACK This package is contained within the CARTON (0085-1934-03) Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing levitra sulfur Date NDA NDA021400 05/15/2008 Labeler - Schering Plough Corporation (001317601) Registrant - Bayer HealthCare Pharmaceuticals Inc. Effects of Levitra on other drugs In vitro studies: Vardenafil and its metabolites had no effect on CYP1A2, 2A6, and 2E1 (Ki >100 µM). In some patients the use of PDE5 inhibitor drugs, including levitra sulfur with alpha-blockers can lower blood pressure significantly leading to fainting. Therefore, the use of such combinations is not recommended. This has occurred in a small number of people taking Levitra, most of whom also had heart disease, diabetes, high blood pressure, high cholesterol, or certain pre-existing eye problems, and in those who smoke or are over 50 years old.
Online pharmacy Tags
70 71 72 73 74 75 76 77 78
.
